Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Recruitment Status: Active, not recruiting"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Glomerulosclerosis%2C+Focal+Segmental%22&type=Subject&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Active%2C+not+recruiting%22
/vufind/Search/Results?lookfor=%22Glomerulosclerosis%2C+Focal+Segmental%22&type=Subject&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Active%2C+not+recruiting%22
Search /vufind/Search2/Results?lookfor=%22Glomerulosclerosis%2C+Focal+Segmental%22&type=Subject&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Active%2C+not+recruiting%22
PubPharm (6)
1
Atrasentan in Patients With Proteinuric Glomerular Diseases : A Phase 2, Open-Label, Basket Study of Atrasentan in Patients With Proteinuric Glomerular Diseases
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
2
Atrasentan in Patients With Proteinuric Glomerular Diseases : A Phase 2, Open-Label, Basket Study of Atrasentan in Patients With Proteinuric Glomerular Diseases
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
3
Randomized, Double-Blind, Safety and Efficacy Study of RE-021 (Sparsentan) in Focal Segmental Glomerulosclerosis : Efficacy and Safety of RE-021, a Dual Endothelin Receptor and Angiotensin Receptor Blocker, in Patients With Focal Segmental Glomerulosclerosis (FSGS): a Randomized, Double-Blind, Active-Control, Dose-Escalation Study
enthalten in:
ClinicalTrials.gov
| 2023
Wird geladen...
4
Study of Sparsentan in Patients With Primary Focal Segmental Glomerulosclerosis (FSGS) : A Randomized, Multicenter, Double-blind, Parallel, Active-control Study of the Effects of Sparsentan, a Dual Endothelin Receptor and Angiotensin Receptor Blocker, on Renal Outcomes in Patients With Primary FSGS
enthalten in:
ClinicalTrials.gov
| 2023
Wird geladen...
5
Obinutuzumab in Primary FSGS : A Single-center, Phase 2 Open-label Trial Evaluating the Efficacy and Safety of OBINUTUZUMAB in Treatment of Immunosuppression-dependent or Immunosuppression/Treatment-resistant Primary FSGS, or Contraindication/Patient Refusal to Take High Dose Corticosteroids
enthalten in:
ClinicalTrials.gov
| 2023
Wird geladen...
6
Genetic Causes of FSGS, Nephrotic Syndrome, or Kidney Failure : Molecular and Genetic Analysis of Inherited Kidney Dysfunction
enthalten in:
ClinicalTrials.gov
| 2023
Wird geladen...
1
[1]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Thema: Recruitment Status: Active, not recruiting
Medienart
6
Aufsätze
6
E-Artikel
6
E-Ressourcen
Zeitschriftentitel
6
ClinicalTrials.gov
Thema
6
610
6
Glomerulosclerosis, Focal Segmental
Recruitment Status: Active, not recruiting
5
Study Type: Interventional
4
Phase: Phase 2
3
Kidney Diseases
2
Diabetic Nephropathies
2
Glomerulonephritis, IGA
2
Nephritis, Hereditary
1
Kidney Failure, Chronic
1
Nephrosis
1
Nephrotic Syndrome
1
Phase: Phase 3
1
Proteinuria
1
Renal Insufficiency
1
Study Type: Observational
1
Syndrome
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
2
2024
4
2023
Erscheinungsjahr(e)
Von:
Bis:
Sprache
6
Englisch
Haven't found what you're looking for?
Wird geladen...